|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/46 | (2006.01) |
| A61P 1/00 | (2006.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61K 31/4748 | (2006.01) | ||
| A61K 31/497 | (2006.01) | ||
| A61K 31/506 | (2006.01) |
| (11) | Number of the document | 3419625 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17709189.9 |
| Date of filing the European patent application | 2017-02-20 | |
| (97) | Date of publication of the European application | 2019-01-02 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-07 |
| (46) | Date of publication of the claims translation | 2021-07-26 |
| (86) | Number | PCT/IB2017/050963 |
| Date | 2017-02-20 |
| (87) | Number | WO 2017/145041 |
| Date | 2017-08-31 |
| (30) | Number | Date | Country code |
| 201662298121 P | 2016-02-22 | US | |
| 201662420661 P | 2016-12-12 | US |
| (72) |
LAFFITTE, Bryan, US
BADMAN, Michael, US
CHEN, Jin, US
LINDGREN, Sam, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | FXR agonistų panaudojimo būdai |
| METHODS FOR USING FXR AGONISTS |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-02-20 |